Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Net Margin (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Net Margin for 6 consecutive years, with 10.79% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin fell 989.0% year-over-year to 10.79%, compared with a TTM value of 26.66% through Dec 2025, up 12.0%, and an annual FY2025 reading of 26.66%, up 12.0% over the prior year.
  • Net Margin was 10.79% for Q4 2025 at Treace Medical Concepts, up from 32.62% in the prior quarter.
  • Across five years, Net Margin topped out at 0.9% in Q4 2024 and bottomed at 57.51% in Q2 2022.
  • Average Net Margin over 5 years is 28.39%, with a median of 30.82% recorded in 2022.
  • The sharpest move saw Net Margin crashed -3272bps in 2022, then surged 2803bps in 2023.
  • Year by year, Net Margin stood at 19.79% in 2021, then soared by 55bps to 8.86% in 2022, then decreased by -16bps to 10.25% in 2023, then soared by 91bps to 0.9% in 2024, then plummeted by -1098bps to 10.79% in 2025.
  • Business Quant data shows Net Margin for TMCI at 10.79% in Q4 2025, 32.62% in Q3 2025, and 36.97% in Q2 2025.